From: A research pathway for the study of the delivery and disposition of nebulised antibiotics: an incremental approach from in vitro to large animal models
ELF time points
Nebulised tobramycin
Intravenous tobramycin
1Â h (mg/l)
1.94
0.19
6Â h (mg/l)
0.07
0.38
AUCELF (mg-h/l)
5.99
1.52
AUCplasma (mg-h/l)
56.88
53.60
AUClung/AUCplasma (mg-h/l)
0.11
0.03